403 related articles for article (PubMed ID: 24171373)
1. Evaluation of a modified proportional margins approach for surgical resection of mast cell tumors in dogs: 40 cases (2008-2012).
Pratschke KM; Atherton MJ; Sillito JA; Lamm CG
J Am Vet Med Assoc; 2013 Nov; 243(10):1436-41. PubMed ID: 24171373
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
3. Surgically planned versus histologically measured lateral tumor margins for resection of cutaneous and subcutaneous mast cell tumors in dogs: 46 cases (2010-2013).
Risselada M; Mathews KG; Griffith E
J Am Vet Med Assoc; 2015 Jul; 247(2):184-9. PubMed ID: 26133218
[TBL] [Abstract][Full Text] [Related]
4. Long-term postsurgical outcomes of mast cell tumors resected with a margin proportional to the tumor diameter in 23 dogs.
Itoh T; Kojimoto A; Uchida K; Chambers J; Shii H
J Vet Med Sci; 2021 Feb; 83(2):230-233. PubMed ID: 33342962
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
6. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
[TBL] [Abstract][Full Text] [Related]
8. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G
J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107
[TBL] [Abstract][Full Text] [Related]
9. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
10. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.
Selmic LE; Ruple A
BMC Vet Res; 2020 Jan; 16(1):5. PubMed ID: 31906934
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
13. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
[TBL] [Abstract][Full Text] [Related]
15. Additional local therapy with primary re-excision or radiation therapy improves survival and local control after incomplete or close surgical excision of mast cell tumors in dogs.
Kry KL; Boston SE
Vet Surg; 2014 Feb; 43(2):182-9. PubMed ID: 24392683
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neoadjuvant prednisone administration and surgical excision in treatment of cutaneous mast cell tumors in dogs.
Stanclift RM; Gilson SD
J Am Vet Med Assoc; 2008 Jan; 232(1):53-62. PubMed ID: 18167109
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lateral surgical margins of up to two centimeters with margins of three centimeters for achieving tumor-free histologic margins following excision of grade I or II cutaneous mast cell tumors in dogs.
Chu ML; Hayes GM; Henry JG; Oblak ML
J Am Vet Med Assoc; 2020 Mar; 256(5):567-572. PubMed ID: 32068517
[TBL] [Abstract][Full Text] [Related]
19. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
